Literature DB >> 17406266

Silencing gene expression by targeting chromosomal DNA with antigene peptide nucleic acids and duplex RNAs.

Bethany A Janowski1, Jiaxin Hu, David R Corey.   

Abstract

The value of recognizing cellular RNA sequences by short interfering RNAs (siRNAs) in mammalian cells is widely appreciated, but what might be learned if it were also possible to recognize chromosomal DNA? Recognition of chromosomal DNA would have many applications, such as inhibiting gene expression, activating gene expression, introducing mutations, and probing chromosome structure and function. We have shown that antigene peptide nucleic acids (agPNAs) and antigene duplex RNAs (agRNAs) block gene expression and probe chromosomal DNA. Here we describe a protocol for designing antigene agents and introducing them into cells. This protocol can also be used to silence expression with PNAs or siRNAs that target mRNA. From preparation of oligomers to analysis of data, experiments with agPNAs and agRNAs require approximately 14 d and 9 d, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17406266     DOI: 10.1038/nprot.2006.64

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  17 in total

Review 1.  Chemical modification: the key to clinical application of RNA interference?

Authors:  David R Corey
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

2.  Antisense and antigene inhibition of gene expression by cell-permeable oligonucleotide-oligospermine conjugates.

Authors:  Keith T Gagnon; Jonathan K Watts; Hannah M Pendergraff; Christophe Montaillier; Danielle Thai; Pierre Potier; David R Corey
Journal:  J Am Chem Soc       Date:  2011-05-12       Impact factor: 15.419

3.  Allele-selective inhibition of ataxin-3 (ATX3) expression by antisense oligomers and duplex RNAs.

Authors:  Jiaxin Hu; Keith T Gagnon; Jing Liu; Jonathan K Watts; Jeja Syeda-Nawaz; C Frank Bennett; Eric E Swayze; John Randolph; Jyoti Chattopadhyaya; David R Corey
Journal:  Biol Chem       Date:  2011-02-07       Impact factor: 3.915

4.  Effect of chemical modifications on modulation of gene expression by duplex antigene RNAs that are complementary to non-coding transcripts at gene promoters.

Authors:  Jonathan K Watts; Dongbo Yu; Klaus Charisse; Christophe Montaillier; Pierre Potier; Muthiah Manoharan; David R Corey
Journal:  Nucleic Acids Res       Date:  2010-04-19       Impact factor: 16.971

5.  Inhibiting gene expression with locked nucleic acids (LNAs) that target chromosomal DNA.

Authors:  Randall L Beane; Rosalyn Ram; Sylvie Gabillet; Khalil Arar; Brett P Monia; David R Corey
Journal:  Biochemistry       Date:  2007-05-31       Impact factor: 3.162

6.  Inhibiting gene expression with peptide nucleic acid (PNA)--peptide conjugates that target chromosomal DNA.

Authors:  Jiaxin Hu; David R Corey
Journal:  Biochemistry       Date:  2007-05-31       Impact factor: 3.162

7.  Functional specialization of Piwi proteins in Paramecium tetraurelia from post-transcriptional gene silencing to genome remodelling.

Authors:  Khaled Bouhouche; Jean-François Gout; Aurélie Kapusta; Mireille Bétermier; Eric Meyer
Journal:  Nucleic Acids Res       Date:  2011-01-07       Impact factor: 16.971

8.  A sequence-specific threading tetra-intercalator with an extremely slow dissociation rate constant.

Authors:  Garen G Holman; Maha Zewail-Foote; Amy Rhoden Smith; Kenneth A Johnson; Brent L Iverson
Journal:  Nat Chem       Date:  2011-09-25       Impact factor: 24.427

9.  Small RNAs targeting transcription start site induce heparanase silencing through interference with transcription initiation in human cancer cells.

Authors:  Guosong Jiang; Liduan Zheng; Jiarui Pu; Hong Mei; Jun Zhao; Kai Huang; Fuqing Zeng; Qiangsong Tong
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

10.  Epigenetics in Friedreich's Ataxia: Challenges and Opportunities for Therapy.

Authors:  Chiranjeevi Sandi; Sahar Al-Mahdawi; Mark A Pook
Journal:  Genet Res Int       Date:  2013-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.